Michael O. Childress

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Integration of Biodynamic Imaging and RNA-seq classifies chemotherapy response in canine diffuse large B-cell lymphoma”.

Integration of Biodynamic Imaging and RNA-seq classifies chemotherapy response in canine diffuse large B-cell lymphoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.11.290353

N/A

0DataRank · unranked

0 citations

Sagar M. Utturkar, Deepika Dhawan, Phillip San Miguel, Gaurav Chopra, John Turek +4 more

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0315

N/A

0DataRank · unranked

55 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog Breed

Bladder Cancer(2021)10.3233/blc-201523

N/A

0DataRank · unranked

11 citations

Deepika Dhawan, Audrey Ruple, José A. Ramos‐Vara, Noah M. Hahn, Sagar M. Utturkar +8 more

Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

(2023)10.1158/1078-0432.c.6529898

N/A

0DataRank · unranked

0 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

(2023)10.1158/1078-0432.c.6529898.v1

N/A

0DataRank · unranked

0 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.22.654354

N/A

0DataRank · unranked

1 citations

Spencer M. Richardson, Leah A. Everitt, Gabrielle J. Knafler, Gavin P. Kinsella, Alyssa L. Walker +14 more

Younger Age Is Associated with Favorable Outcomes in Adult Dogs with Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results from the PRO-DOX Study

Research Square(2025)10.21203/rs.3.rs-6573099/v1

N/A

0DataRank · unranked

0 citations

Brian D. Husbands, Aaron L. Sarver, Jeremy M. Chacón, Todd E. DeFor, Aaron Rendahl +18 more

Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0121

N/A

0DataRank · unranked

0 citations

Spencer M. Richardson, Leah A. Everitt, Gabrielle J. Knafler, Alyssa L. Walker, Venetia A. Whiteside +18 more